Always ask your doctor before making any changes
The forthcoming surge of obesity drugs is bound to move these edges, providing additional choices for patients and providers alike
With Wegovy the reduction of MACE was not impacted by age, sex, race, ethnicity, BMI at baseline, or level of renal function impairment 1 The exact mechanism of cardiovascular risk reduction of Wegovy has not been established
The cost of retatrutide varies significantly between vendors, and SeekPeptides provides comparison tools to help navigate options
But it can be an avenue for people who are struggling to get to that next step. This article originally appeared as A Balanced Approach to Weight-Loss Drugs in the March/April 2025 issue of Experience Life.
It complements dietary tweaks by supporting metabolic efficiencies, which could amplify weight management efforts